(Q43039523)

English

Occurrence of hepatocellular carcinoma was not a rare event during and immediately after antiviral treatment in Japanese HCV-positive patients

scientific article published on 3 August 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Occurrence of hepatocellular carcinoma was not a rare event during and immediately after antiviral treatment in Japanese HCV-positive patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Keiichi Fujiwara

9

object named as

Keiichi Fujiwara

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

author name string

Tatsuo Kanda

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Fumio Imazeki

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Shigeru Mikami

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Keizo Kato

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Noritomo Shimada

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Yutaka Yonemitsu

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Tomoo Miyauchi

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Makoto Arai

8

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Akihito Tsubota

10

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Nobuo Takada

11

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Takayoshi Nishino

12

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Motohide Takashi

13

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Nobuyuki Sugiura

14

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Michio Kimura

15

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Kenichi Fukai

16

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Osamu Yokosuka

17

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

3 August 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

80

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

5-6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

366-372

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Trends in health care resource use for hepatitis C virus infection in the United States

1 reference

https://api.crossref.org/works/10.1159%2F000330549

21 January 2018

State of hepatitis C viral replication enhances activation of NF-kB- and AP-1-signaling induced by hepatitis B virus X.

1 reference

https://api.crossref.org/works/10.1159%2F000330549

21 January 2018

New antiviral therapies for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1159%2F000330549

21 January 2018

Effects of interferon treatment on development and progression of hepatocellular carcinoma in patients with chronic virus infection: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1159%2F000330549

21 January 2018

Favorable prognosis of chronic hepatitis C after interferon therapy by long-term cohort study

1 reference

https://api.crossref.org/works/10.1159%2F000330549

21 January 2018

Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosis

1 reference

https://api.crossref.org/works/10.1159%2F000330549

21 January 2018

Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis

1 reference

https://api.crossref.org/works/10.1159%2F000330549

21 January 2018

Outcome of sustained virological responders with histologically advanced chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1159%2F000330549

21 January 2018

Editorial : Treatment of Patients With HCV-Related Cirrhosis With Peginterferon and Ribavirin: Swinging the Pendulum Toward Treatment

1 reference

https://api.crossref.org/works/10.1159%2F000330549

21 January 2018

Does chemotherapy prevent HCV-related hepatocellular carcinoma? Cons

1 reference

https://api.crossref.org/works/10.1159%2F000330549

21 January 2018

Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: A 5-year follow-up of 150 patients

1 reference

https://api.crossref.org/works/10.1159%2F000330549

21 January 2018

Hepatocellular carcinoma appearance in patients with hepatitis C virus-related chronic liver disease 90 and 70 months after sustained virological response to interferon and ribavirin

1 reference

https://api.crossref.org/works/10.1159%2F000330549

21 January 2018

Simple assay based on restriction fragment length polymorphism associated with IL28B in chronic hepatitis C patients

1 reference

https://api.crossref.org/works/10.1159%2F000330549

21 January 2018

Quantification of hepatitis C virus in patients treated with peginterferon-alfa 2a plus ribavirin treatment by COBAS TaqMan HCV test

1 reference

https://api.crossref.org/works/10.1159%2F000330549

21 January 2018

Ultrasound surveillance for early detection of hepatocellular carcinoma among patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1159%2F000330549

21 January 2018

Association between mutations in the core region of hepatitis C virus genotype 1 and hepatocellular carcinoma development

1 reference

https://api.crossref.org/works/10.1159%2F000330549

21 January 2018

Pegylated interferon α-2b plus ribavirin for older patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1159%2F000330549

21 January 2018

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1159%2F000330549

21 January 2018

Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon

1 reference

https://api.crossref.org/works/10.1159%2F000330549

21 January 2018

Hepatocellular carcinoma in the Asia pacific region

1 reference

https://api.crossref.org/works/10.1159%2F000330549

21 January 2018

Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.

1 reference

https://api.crossref.org/works/10.1159%2F000330549

21 January 2018

Detection of hepatocellular carcinoma after interferon therapy for chronic hepatitis C: clinical study of 26 cases

1 reference

https://api.crossref.org/works/10.1159%2F000330549

21 January 2018

Future hepatitis C virus treatment: interferon-sparing combinations

1 reference

https://api.crossref.org/works/10.1159%2F000330549

21 January 2018

Delayed development of hepatocellular carcinoma during long-term follow-up after eradication of hepatitis C virus by interferon therapy

1 reference

https://api.crossref.org/works/10.1159%2F000330549

21 January 2018

Identifiers

10.1159/000330549

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43039523&oldid=1978308825"